Page last updated: 2024-09-04

levofloxacin and Obesity, Morbid

levofloxacin has been researched along with Obesity, Morbid in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's4 (80.00)24.3611
2020's1 (20.00)2.80

Authors

AuthorsStudies
Booker, C; Jacobson, R; Khalid, S; Omotosho, P; Terranella, S; Torquati, A1
Cerqueira, RM; Correia, M; Manso, MC; Vilar, H1
Cojutti, P; Pai, MP; Pea, F1
Colino, CI; Ferrer, A; Grau, S; Luque, S; Valle, M1
Cerqueira, RM; Correia, MR; Fernandes, CD; Manso, MC; Vilar, H1

Other Studies

5 other study(ies) available for levofloxacin and Obesity, Morbid

ArticleYear
The Impact of Perioperative Antibiotic Prophylaxis on Weight Loss Following Laparoscopic Sleeve Gastrectomy.
    Journal of laparoendoscopic & advanced surgical techniques. Part A, 2020, Volume: 30, Issue:9

    Topics: Adult; Anti-Bacterial Agents; Antibiotic Prophylaxis; Bariatric Surgery; Cefoxitin; Female; Gastrectomy; Humans; Laparoscopy; Levofloxacin; Male; Metronidazole; Middle Aged; Obesity, Morbid; Postoperative Period; Retrospective Studies; Treatment Outcome; Weight Loss

2020
Cumulative Helicobacter Pylori Eradication Rates by Adopting First- and Second- Line Regimens Proposed by the Maastricht IV Consensus in Obese Patients Undergoing Gastric Bypass Surgery.
    Obesity surgery, 2018, Volume: 28, Issue:3

    Topics: Adolescent; Adult; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Consensus; Drug Therapy, Combination; Female; Gastric Bypass; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Middle Aged; Obesity, Morbid; Prospective Studies; Proton Pump Inhibitors; Young Adult

2018
Levofloxacin dosing regimen in severely morbidly obese patients (BMI ≥40 kg/m(2)) should be guided by creatinine clearance estimates based on ideal body weight and optimized by therapeutic drug monitoring.
    Clinical pharmacokinetics, 2014, Volume: 53, Issue:8

    Topics: Adolescent; Adult; Anti-Bacterial Agents; Area Under Curve; Bayes Theorem; Body Mass Index; Body Surface Area; Databases, Factual; Dose-Response Relationship, Drug; Drug Monitoring; Female; Humans; Ideal Body Weight; Kidney Function Tests; Levofloxacin; Male; Metabolic Clearance Rate; Middle Aged; Models, Biological; Monte Carlo Method; Obesity, Morbid; Severity of Illness Index; Young Adult

2014
Levofloxacin weight-adjusted dosing and pharmacokinetic disposition in a morbidly obese patient.
    The Journal of antimicrobial chemotherapy, 2011, Volume: 66, Issue:7

    Topics: Anti-Bacterial Agents; Body Weight; Humans; Infusions, Intravenous; Levofloxacin; Middle Aged; Obesity, Morbid; Ofloxacin; Pneumococcal Infections

2011
Cumulative Helicobacter pylori eradication therapy in obese patients undergoing gastric bypass surgery.
    Obesity surgery, 2013, Volume: 23, Issue:2

    Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Gastric Bypass; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Middle Aged; Obesity, Morbid; Ofloxacin; Portugal; Practice Guidelines as Topic; Proton Pump Inhibitors; Risk Factors; Stomach Neoplasms; Surgical Wound Infection; Treatment Failure; Young Adult

2013
chemdatabank.com